CompletedNot Applicable

Dextrose Prolotherapy Versus LLLT in Treatment of Obstructive Sleep Apnea

Egypt26 participantsStarted 2023-04-12

Plain-language summary

This study was conducted on 26 patients with obstructive sleep apnea. The patients were divided randomly and equally into two equal groups. In group I, the patients were treated with LLLT, while in group II, the patients were treated with dextrose injection. The patients were evaluated by: Medical history utilizing sleep unit medical sheet, physical examination including: anthropometric measures, epworth sleepiness scale, and Berlin questioner, and Polysomnography

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Pregnant patients
✕. Active infectious disease (flu like symptoms).
✕. Serious co-morbidity such as chronic or decompensated liver disease, and chronic kidney disease with creatinine clearance less than 30%.
✕. Patients with neuromuscular disorders.
✕. Previous trauma to the head, and neck.
✕. Obvious fixed upper airway obstructions (tumors, polyps, nasal obstruction).
✕. Tonsil size ≥ +3.
✕. Clinical evidence of severe chronic obstructive or restrictive pulmonary disease (for example chronic bronchitis, emphysema, pulmonary fibrosis).

What they're measuring

Epworth sleepiness scale

Timeframe: 1 week after last treatment session.

Polysomnography

Timeframe: 1 week after last treatment session.

Trial details

NCT IDNCT06427161

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-05

View on ClinicalTrials.gov More Obstructive Sleep Apnea trials